EP3401334
Einklóna mótefni gegn claudin-18 í meðferð við krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.5.2008EP published:
15.2.2023EP application number:
18168460.6
EP translation filed:
20.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
26.5.2028Expiry date:
26.5.2026Next due date:
31.5.2026
Title in English:
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
27.5.2008EP application
15.2.2023EP Publication
20.3.2023Translation submitted
15.4.2023Registration published
26.5.2026Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
BRANDENBURG, GundaAddress:
22880 Wedel, DE
Name:
USENER, DirkAddress:
65193 Wiesbaden, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
07010622Date:
29.5.2007Country:
EP
Number:
932099 PDate:
29.5.2007Country:
US
Classification
Categories:
C07K 16/30, C12N 5/12, A61P 35/00, A61K 39/395, A61P 43/00, A61P 35/04, A61P 37/04, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 24.5.2023
Expires: 26.5.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.5.2024
Expires: 26.5.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 16.5.2025
Expires: 26.5.2026
Payer: Árnason Faktor ehf.